Since its discovery, lithium has been shown to act upon various neurotransm
itter systems at multiple levels of signaling in the brain. Lithium, affect
ing each neurotransmitter system within complex interactive neuronal networ
ks, is suggested to restore the balance among aberrant signaling pathways i
n critical regions of the brain. Recent molecular studies have revealed the
action of lithium on signal transduction mechanisms, such as phosphoinosit
ide hydrolysis, adenylyl cyclase, G protein, glycogen synthase kinase-3 bet
a, protein kinase C, and its substrate myristoylated alanine-rich C kinase
substrate. Such effects are thought to trigger long-term changes in neurona
l signaling patterns that account for the prophylactic properties of lithiu
m in the treatment of bipolar disorder. Through its effects on glycogen syn
thase kinase-3 beta and protein kinase C, lithium may alter the level of ph
osphorylation of cytoskeletal proteins, which leads to neuroplastic changes
associated with mood stabilization. Chronic lithium regulates transcriptio
nal factors, which in turn may modulate the expression of a variety of gene
s that compensate for aberrant signaling associated with the pathophysiolog
y of bipolar disorder. Future studies on long-term neuroplastic changes cau
sed by lithium in the brain will set the stage for new drug-discovery oppor
tunities.